Bay Street News, November 9th, 2018

–CRISPR Therapeutics Gains Additional Rights to MaxCyte’s Cell Engineering Technology to Develop CRISPR/Cas9-Based Cell Therapies in Immuno-Oncology– ZUG, Switzerland and […]

CHICAGO, Nov. 09, 2018 (GLOBE NEWSWIRE) — Potbelly Corporation (NASDAQ: PBPB) today reported financial results for the third fiscal quarter […]

NEW HAVEN, Conn., Nov. 09, 2018 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI), a clinical stage biopharmaceutical development […]

Presentation to be Webcast and Archived BRIDGEVILLE, Pa., Nov. 09, 2018 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. […]

Final Phase 3 results of AXS-05 in treatment resistant depression now anticipated in 1Q 2019 Final Phase 2 results of […]

BEIJING, Nov. 09, 2018 (GLOBE NEWSWIRE) — RISE Education Cayman Ltd (“RISE” or the “Company”) (NASDAQ: REDU), a leading junior […]

LOS ANGELES, Nov. 09, 2018 (GLOBE NEWSWIRE) — Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer […]

CHESTERFIELD, Mo., Nov. 09, 2018 (GLOBE NEWSWIRE) — Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal […]

Company to host conference call today at 8:30am ET  DALLAS and FORT WORTH, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) — […]

– Oncolytic virus enhances immune checkpoint inhibitor response in prostate cancers – CALGARY, Alberta and SAN DIEGO, Nov. 09, 2018 […]